BOIRON SA (BOI.PA) Stock Fundamental Analysis

EPA:BOI • FR0000061129

29.85 EUR
+0.35 (+1.19%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Overall BOI gets a fundamental rating of 4 out of 10. We evaluated BOI against 55 industry peers in the Pharmaceuticals industry. While BOI has a great health rating, there are worries on its profitability. BOI has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • BOI had positive earnings in the past year.
  • BOI had a positive operating cash flow in the past year.
  • In the past 5 years BOI has always been profitable.
  • In the past 5 years BOI always reported a positive cash flow from operatings.
BOI.PA Yearly Net Income VS EBIT VS OCF VS FCFBOI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

  • BOI's Return On Assets of 3.45% is on the low side compared to the rest of the industry. BOI is outperformed by 63.64% of its industry peers.
  • The Return On Equity of BOI (5.25%) is worse than 61.82% of its industry peers.
  • The Return On Invested Capital of BOI (4.43%) is worse than 61.82% of its industry peers.
  • BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 14.21%.
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROIC 4.43%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
BOI.PA Yearly ROA, ROE, ROICBOI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • With a Profit Margin value of 3.84%, BOI is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
  • BOI's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 5.26%, BOI is doing worse than 63.64% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BOI has declined.
  • Looking at the Gross Margin, with a value of 73.71%, BOI is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • BOI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
BOI.PA Yearly Profit, Operating, Gross MarginsBOI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOI is destroying value.
  • BOI has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BOI has less shares outstanding
  • Compared to 1 year ago, BOI has a worse debt to assets ratio.
BOI.PA Yearly Shares OutstandingBOI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BOI.PA Yearly Total Debt VS Total AssetsBOI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BOI has an Altman-Z score of 3.76. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
  • BOI has a Altman-Z score (3.76) which is comparable to the rest of the industry.
  • BOI has a debt to FCF ratio of 0.49. This is a very positive value and a sign of high solvency as it would only need 0.49 years to pay back of all of its debts.
  • The Debt to FCF ratio of BOI (0.49) is better than 92.73% of its industry peers.
  • A Debt/Equity ratio of 0.04 indicates that BOI is not too dependend on debt financing.
  • BOI has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. BOI outperforms 89.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Altman-Z 3.76
ROIC/WACC0.54
WACC8.13%
BOI.PA Yearly LT Debt VS Equity VS FCFBOI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

  • A Current Ratio of 2.39 indicates that BOI has no problem at all paying its short term obligations.
  • BOI's Current ratio of 2.39 is fine compared to the rest of the industry. BOI outperforms 78.18% of its industry peers.
  • A Quick Ratio of 1.46 indicates that BOI should not have too much problems paying its short term obligations.
  • The Quick ratio of BOI (1.46) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.46
BOI.PA Yearly Current Assets VS Current LiabilitesBOI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for BOI have decreased strongly by -18.09% in the last year.
  • BOI shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.40% yearly.
  • Looking at the last year, BOI shows a small growth in Revenue. The Revenue has grown by 4.80% in the last year.
  • Measured over the past years, BOI shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%

3.2 Future

  • Based on estimates for the next years, BOI will show a small growth in Earnings Per Share. The EPS will grow by 2.73% on average per year.
  • Based on estimates for the next years, BOI will show a small growth in Revenue. The Revenue will grow by 5.54% on average per year.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BOI.PA Yearly Revenue VS EstimatesBOI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
BOI.PA Yearly EPS VS EstimatesBOI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 26.65 indicates a quite expensive valuation of BOI.
  • BOI's Price/Earnings ratio is a bit more expensive when compared to the industry. BOI is more expensive than 60.00% of the companies in the same industry.
  • BOI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.97.
  • With a Price/Forward Earnings ratio of 12.91, BOI is valued correctly.
  • Based on the Price/Forward Earnings ratio, BOI is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • BOI is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.65
Fwd PE 12.91
BOI.PA Price Earnings VS Forward Price EarningsBOI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BOI is valued cheaply inside the industry as 94.55% of the companies are valued more expensively.
  • 83.64% of the companies in the same industry are more expensive than BOI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.05
EV/EBITDA 6.54
BOI.PA Per share dataBOI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.82
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • BOI has a Yearly Dividend Yield of 4.07%, which is a nice return.
  • BOI's Dividend Yield is rather good when compared to the industry average which is at 1.92. BOI pays more dividend than 83.64% of the companies in the same industry.
  • BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
Industry RankSector Rank
Dividend Yield 4.07%

5.2 History

  • The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
BOI.PA Yearly Dividends per shareBOI.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

  • BOI pays out 107.57% of its income as dividend. This is not a sustainable payout ratio.
DP107.57%
EPS Next 2Y2.73%
EPS Next 3YN/A
BOI.PA Yearly Income VS Free CF VS DividendBOI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BOI.PA Dividend Payout.BOI.PA Dividend Payout, showing the Payout Ratio.BOI.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BOIRON SA

EPA:BOI (2/13/2026, 7:00:00 PM)

29.85

+0.35 (+1.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)04-02
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap523.87M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.07%
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP107.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 26.65
Fwd PE 12.91
P/S 1.04
P/FCF 14.05
P/OCF 9.9
P/B 1.42
P/tB 2.1
EV/EBITDA 6.54
EPS(TTM)1.12
EY3.75%
EPS(NY)2.31
Fwd EY7.75%
FCF(TTM)2.12
FCFY7.12%
OCF(TTM)3.02
OCFY10.1%
SpS28.77
BVpS21.03
TBVpS14.24
PEG (NY)4.82
PEG (5Y)N/A
Graham Number23.02
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 5.25%
ROCE 5.9%
ROIC 4.43%
ROICexc 5.25%
ROICexgc 7.65%
OM 5.26%
PM (TTM) 3.84%
GM 73.71%
FCFM 7.39%
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexgc growth 3Y-33.41%
ROICexgc growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.49
Debt/EBITDA 0.2
Cap/Depr 35.13%
Cap/Sales 3.1%
Interest Coverage 30.02
Cash Conversion 74.49%
Profit Quality 192.52%
Current Ratio 2.39
Quick Ratio 1.46
Altman-Z 3.76
F-Score7
WACC8.13%
ROIC/WACC0.54
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.09%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%241.06%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.8%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%7.58%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-11.18%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y113.74%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y57.85%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%

BOIRON SA / BOI.PA FAQ

Can you provide the ChartMill fundamental rating for BOIRON SA?

ChartMill assigns a fundamental rating of 4 / 10 to BOI.PA.


What is the valuation status of BOIRON SA (BOI.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BOIRON SA (BOI.PA). This can be considered as Fairly Valued.


How profitable is BOIRON SA (BOI.PA) stock?

BOIRON SA (BOI.PA) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for BOI stock?

The Price/Earnings (PE) ratio for BOIRON SA (BOI.PA) is 26.65 and the Price/Book (PB) ratio is 1.42.


Is the dividend of BOIRON SA sustainable?

The dividend rating of BOIRON SA (BOI.PA) is 5 / 10 and the dividend payout ratio is 107.57%.